Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded ATP synthase 6 pseudogene 3 (MTATP6P3) is a nuclear-encoded pseudogene homologous to the mitochondrial gene MT-ATP6, which encodes a vital subunit of mitochondrial ATP synthase responsible for ATP production[1][2][7]. As a pseudogene, MTATP6P3 does not encode a functional protein and has no known biological, disease, or pharmacological roles. It should not be mistaken for the functional MT-ATP6 gene, whose mutations are associated with mitochondrial disorders such as Leigh syndrome and NARP syndrome[1][2][4][5]. Pseudogenes like MTATP6P3 may arise from duplication or transfer events but do not produce active gene products or serve as drug targets. If seeking information on therapeutic targets, the correct molecule is the functional MT-ATP6 gene, not MTATP6P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded ATP synthase 6 pseudogene 3 (MTATP6P3).